Hopkinson Craig C.

Insider

EVP R&D, Chief Medical Officer

Trades at: ALKS· ALBO

30D 90D 1Y

Net shares · 90d

-27.0K

0 buy · 27.0K sell

Net value · 90d

-$995.2K

$0 in · $995.2K out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

0 buy · 27.0K sell

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 90d

Open-market Buys Sells All types

ALKS Sell·S
Jun 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$375.0K

9.0K sh · $41.67

Own -10%
ALKS Sell·S
May 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$300.6K

9.0K sh · $33.40

Own -10%
ALKS Sell·S
Apr 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$319.6K

9.0K sh · $35.51

Own -10%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
Jun 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Sell S	9.0K	-10%	$41.67	$375.0K
May 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Sell S	9.0K	-10%	$33.40	$300.6K
Apr 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Sell S	9.0K	-10%	$35.51	$319.6K

Buy Sell Non-market (grant · exercise · gift)

About Hopkinson Craig C.

This profile aggregates every SEC Form 4 insider transaction reported by Hopkinson Craig C. across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.